CircRNA RNA hsa_circ_0008234 Promotes Colon Cancer Progression by Regulating the miR-338-3p/ETS1 Axis and PI3K/AKT/mTOR Signaling

Simple Summary Circular RNAs (circRNAs) exert an important role in cancer progression. Meanwhile, considering its widespread regulatory effect and the potential of noninvasive testing, understanding the role of circRNA in cancer is particularly meaningful. Our study identified the circRNA hsa_circ_0008234 in colon cancer based on an open-accessed circRNAs expression profile. Moreover, we found that hsa_circ_0008234 could promote proliferation, invasion, and migration abilities of colon cancers, which was partly dependent on the competitive endogenous RNA mechanism (miR-338-3p/ETS1 axis). Meanwhile, we discovered that PI3K/AKT/mTOR signaling is the downstream pathway of the has_circ_0008234/miR-338-3p/ETS1 axis, which improves the effect network of circRNAs in colon cancer. Abstract Circular RNAs (circRNAs) have been shown to play a crucial role in cancer occurrence and progression. This present work investigated the link between hsa_circ_0008234 and colon cancer. Data retrieved from GSE172229 was used to compare the circRNA profiles of colon cancer and surrounding non-tumorous tissues. The amount of RNA and protein in the molecules was determined using quantitative real-time PCR (qRT-PCR) and Western blot analysis, respectively. The cell proliferation ability was assessed using CCK8, EdU, colon formation, and nude mice tumorigenesis tests. Cell invasion and migration abilities were evaluated using transwell wound healing and mice lung metastasis model. Hsa_circ_0008234 piqued our interest because bioinformatics and qRT-PCR analyses revealed that it is upregulated in colon cancer tissue. Cell phenotypic studies suggest that hsa_circ_0008234 may significantly increase colon cancer cell aggressiveness. Mice experiments revealed that inhibiting hsa_circ_0008234 significantly reduced tumor growth and metastasis. Moreover, the fluorescence in situ hybridization experiment demonstrated that hsa_circ_0008234 is primarily found in the cytoplasm, implying that it potentially functions via a competitive endogenous RNA pathway. These findings indicated that hsa_circ_0008234 may act as a “molecular sponge” for miR-338-3p, increasing the expression of miR-338-target 3p’s ETS1. In addition, the traditional oncogenic pathway PI3K/AKT/mTOR signaling was found to be the potential downstream pathway of the hsa_circ_0008234/miR-338-3p/ETS1 axis. In conclusion, hsa_circ_0008234 increases colon cancer proliferation, infiltration, and migration via the miR-338-3p/ETS1/PI3K/AKT axis; therefore, it could serve as a target and a focus for colon cancer therapy.

[1]  Y. Cho,et al.  Two circPPFIA1s negatively regulate liver metastasis of colon cancer via miR-155-5p/CDX1 and HuR/RAB36 , 2022, Molecular Cancer.

[2]  Hongbing Ma,et al.  circRNA PLOD2 promotes tumorigenesis and Warburg effect in colon cancer by the miR-513a-5p/SIX1/LDHA axis , 2022, Cell cycle.

[3]  Feng Zhang,et al.  RETRACTED ARTICLE: RUNX3-regulated circRNA METTL3 inhibits colorectal cancer proliferation and metastasis via miR-107/PER3 axis , 2022, Cell Death & Disease.

[4]  Yuancai Luo,et al.  Circ_0085315 promotes cell proliferation, invasion, and migration in colon cancer through miR-1200/MAP3K1 signaling pathway , 2022, Cell cycle.

[5]  J. Ouyang,et al.  Circular RNA circCSPP1 promotes the occurrence and development of colon cancer by sponging miR-431 and regulating ROCK1 and ZEB1 , 2022, Journal of translational medicine.

[6]  K. Luo,et al.  CircFOXP1: A novel serum diagnostic biomarker for non-small cell lung cancer , 2022, The International journal of biological markers.

[7]  Ling Cheng,et al.  circ_0038718 promotes colon cancer cell malignant progression via the miR-195-5p/Axin2 signaling axis and also effect Wnt/β-catenin signal pathway , 2021, BMC genomics.

[8]  Jian Wu,et al.  Hsa_circ_0008234 facilitates proliferation of cutaneous squamous cell carcinoma through targeting miR-127-5p to regulate ADCY7 , 2021, Archives of Dermatological Research.

[9]  Burton B. Yang,et al.  Targeting circular RNAs as a therapeutic approach: current strategies and challenges , 2021, Signal Transduction and Targeted Therapy.

[10]  Weiping Yu,et al.  Knockdown of RNA N6-methyladenosine methyltransferase METTL3 represses Warburg effect in colorectal cancer via regulating HIF-1α , 2021, Signal Transduction and Targeted Therapy.

[11]  Jia-Jun Liu,et al.  The depletion of Circ‐PRKDC enhances autophagy and apoptosis in T‐cell acute lymphoblastic leukemia via microRNA‐653‐5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway , 2021, The Kaohsiung journal of medical sciences.

[12]  G. Shan,et al.  CircRNA in cancer: Fundamental mechanism and clinical potential. , 2021, Cancer letters.

[13]  Zengjun Li,et al.  Hsa_circ_0020095 Promotes Oncogenesis and Cisplatin Resistance in Colon Cancer by Sponging miR-487a-3p and Modulating SOX9 , 2021, Frontiers in Cell and Developmental Biology.

[14]  R. Xu,et al.  Circular RNA: metabolism, functions and interactions with proteins , 2020, Molecular Cancer.

[15]  Guanqun Huang,et al.  CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway , 2020, Cell Death & Disease.

[16]  Xinyi Wang,et al.  Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit , 2020, Molecular cancer.

[17]  R. Verhoeven,et al.  Conditional Survival and Cure of Patients With Colon or Rectal Cancer: A Population-Based Study. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[18]  Bo Yu,et al.  RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer , 2020, Journal of Experimental & Clinical Cancer Research.

[19]  Ning Li,et al.  The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway , 2020, Cell Death & Disease.

[20]  Hong-bo Zhu,et al.  circRNA_100859 functions as an oncogene in colon cancer by sponging the miR-217-HIF-1α pathway , 2020, Aging.

[21]  Gang Zhao,et al.  Hsa_circRNA_000166 Promotes Cell Proliferation, Migration and Invasion by Regulating miR-330-5p/ELK1 in Colon Cancer , 2020, OncoTargets and therapy.

[22]  M. Zhuang,et al.  MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway. , 2020, European review for medical and pharmacological sciences.

[23]  L. Qiao,et al.  A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer , 2020, Molecular Cancer.

[24]  Ning Zhang,et al.  circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma , 2020, Theranostics.

[25]  Z. Zeng,et al.  Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA , 2020, Molecular Cancer.

[26]  Mei-Sheng Xiao,et al.  Biogenesis and Functions of Circular RNAs Come into Focus. , 2020, Trends in cell biology.

[27]  Aimin Li,et al.  MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling , 2019, Cell Death & Disease.

[28]  Haiyang Xie,et al.  WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1 , 2019, Molecular Cancer.

[29]  Xiaofei Yan,et al.  LncRNA SNHG6 inhibits cell proliferation and metastasis by targeting ETS1 via the PI3K/AKT/mTOR pathway in colorectal cancer , 2019, Molecular medicine reports.

[30]  Qi Zhou,et al.  A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling , 2019, Molecular Cancer.

[31]  Huaiming Wang,et al.  CircRNA_104916 regulates migration, apoptosis and epithelial-mesenchymal transition in colon cancer cells. , 2019, Frontiers in bioscience.

[32]  Marc A. Thomas,et al.  ETS1 induces transforming growth factor β signaling and promotes epithelial‐to‐mesenchymal transition in prostate cancer cells , 2018, Journal of cellular biochemistry.

[33]  X. Luan,et al.  LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p , 2018, Journal of gynecologic oncology.

[34]  Zhengyu Zhang,et al.  MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  C. Punt,et al.  From tumour heterogeneity to advances in precision treatment of colorectal cancer , 2017, Nature Reviews Clinical Oncology.

[36]  J. Dittmer The role of the transcription factor Ets1 in carcinoma. , 2015, Seminars in cancer biology.

[37]  Wang Ma,et al.  ceRNA in cancer: possible functions and clinical implications , 2015, Journal of Medical Genetics.

[38]  R. Salazar,et al.  Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  E. Westhof,et al.  Biogenesis of Circular RNAs , 2014, Cell.

[40]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Edward Giovannucci,et al.  Modifiable risk factors for colon cancer. , 2002, Gastroenterology clinics of North America.

[42]  Tiantian Zhen,et al.  miR-338-3p suppresses colorectal cancer proliferation and progression by inhibiting MACC1. , 2018, International journal of clinical and experimental pathology.

[43]  He-da Zhang,et al.  CircRNA: a novel type of biomarker for cancer , 2017, Breast Cancer.

[44]  R. Labianca,et al.  Colon cancer. , 2010, Critical reviews in oncology/hematology.